TDOC

Teladoc Health, Inc.

Healthcare · $1.1B market cap

Verdict

We can't put a fair value on TDOC right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-1.4% a year✗
Sales growth35.7% a year✓
Free cash flow growth13.6% a year✓
Return on invested capital-15.7%✗

Follow TDOC

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds TDOC. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: Howard Marks

Insider activity

Since Sep 1, 2026: no open-market purchases, 7 sales worth $348K and 15 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Teladoc Health, Inc.

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works